Sign inJoin waitlistJoin the waitlist

MF

Mark Fleming

Physician · Virginia Oncology Associates

Credentials: · · ·

History

Virginia Oncology Associates
Present

Memorial Sloan Kettering Cancer Center
2002–2004
Internal Medicine
Temple University Hospital
1999–2002
Univ of Toledo Coll of Med
1995–1999

Research

Increased survival with enzalutamide in prostate cancer after chemotherapy
New England Journal of Medicine · 2012 · 3,725 citations
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm,…
The Lancet · 2016 · 2,972 citations
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
New England Journal of Medicine · 2019 · 1,067 citations

GS
Guru Sonpavde
13 papers
Matthew Galsky
13 papers
NS
Neal Shore
7 papers
TH
Thomas Hutson
7 papers
WB
William Berry
7 papers
David Schuster
5 papers
HS
Howard Scher
5 papers
NH
Noah Hahn
5 papers
Andrew Armstrong
4 papers
Benjamin Gartrell
4 papers
Brian Chapin
4 papers
Daniel George
4 papers

Clinical trials

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
Principal investigator · Completed · Phase 2
US Oncology Research
2008–2011